Next Article in Journal
Assessing the Microbial Quality of Shrimp (Xiphonaeus kroyeri) and Mussels (Perna perna) Illegally Sold in the Vitória Region, Brazil, and Investigating the Antimicrobial Resistance of Escherichia coli Isolates
Next Article in Special Issue
Variation in Pen-Level Prevalence of BRD Bacterial Pathogens and Antimicrobial Resistance Following Feedlot Arrival in Beef Calves
Previous Article in Journal
Impact of Genital Infections and Antibiotic Use on Incidence of Preterm Birth: A Retrospective Observational Study
Previous Article in Special Issue
Control of Escherichia coli in Poultry Using the In Ovo Injection Technique
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Multidrug-Resistant Extended-Spectrum Beta-Lactamase (ESBL)-Producing Escherichia coli in a Dairy Herd: Distribution and Antimicrobial Resistance Profiles

1
Department of Veterinary Medicine and Animal Sciences, University of Milan, 26900 Lodi, Italy
2
Department of Humanities and Social Sciences, University of Sassari, 07100 Sassari, Italy
3
Escuela de Graduados, Facultad de Ciencias Veterinarias, Universidad Austral de Chile, Valdivia 5090000, Chile
4
Laboratory of Infectious Diseases of Domestic Animals (MiLab), University of Milan, 26900 Lodi, Italy
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Antibiotics 2024, 13(3), 241; https://doi.org/10.3390/antibiotics13030241
Submission received: 30 January 2024 / Revised: 26 February 2024 / Accepted: 2 March 2024 / Published: 5 March 2024
(This article belongs to the Special Issue Antimicrobial Resistance in Veterinary Science)

Abstract

:
This study investigated the presence, distribution, and antimicrobial resistance profiles of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli in a dairy herd located in Northern Italy. The feces of clinically healthy calves, their mothers, and the cows treated for mastitis, as well as water, environmental samples, and waste milk were collected and subjected to bacteriological culture on CHROMagarTM ESBL plates. A questionnaire was administered to identify risk factors. The isolates were identified as E. coli by MALDI-TOF MS and subjected to the double-disk synergy test (DDST) and minimal inhibitory concentration (MIC) assay. As a result, ESBL E. coli was isolated from the feces of 28 of 37 (75.67%) calves, the feces of 2 of 3 (66.67%) treated cows, 8 of 14 (57.15%) environmental samples, and waste milk. All ESBL isolates showed multiple resistances and were categorized as multidrug-resistant (MDR). Several risk factors for ESBL E. coli selection and diffusion were identified, including lack of routine cleaning of calf feeding and housing equipment, administration of waste milk to male calves, and blanket dry cow therapy. In conclusion, this study highlighted the presence of MDR, ESBL E. coli in the feces of most dairy calves, and their association with different sample sources. Accordingly, adding to the prudent use of antibiotics, the adoption of adequate farm hygiene and biosecurity measures might also help prevent the spread and transmission of ESBL E. coli within the herd.

1. Introduction

Antimicrobial resistance (AMR) is a problem of global concern [1]. The rise in antibiotic-resistant bacteria, as stated by the World Health Organization (WHO), can render many drugs previously essential for treating infections in humans and animals ineffective [2]. About 50–80% of the total antibiotic use in developed countries has been attributed to livestock [3], although significant efforts are being made to reduce antibiotic use. According to a report published by the European Food Safety Authority [4], in Europe antibiotic use has decreased to become lower in food-producing animals than in humans. Between 2016 and 2018, animals used less antimicrobials than humans overall. In 2017, for example, animals averaged 108.3 mg/kg (range 3.1–423.1) compared to 130.0 mg/kg (range 52.8–212.6) for humans [4]. Nevertheless, the animal industry still plays a crucial role in the occurrence and transmission of AMR [5].
In recent years, the prevalence of bacterial strains producing extended-spectrum beta-lactamases (ESBLs) has increased worldwide [6,7]. These enzymes are able to hydrolyze third-generation cephalosporins and aztreonam but are inhibited by clavulanic acid. ESBL-producing organisms often show co-resistance to many other classes of antibiotics. Adding to problems in veterinary medicine, this group of plasmid-mediated, rapidly evolving, and diverse enzymes poses major therapeutic challenges in human medicine, especially concerning the treatment of hospitalized and community-based patients [7].
ESBL-producing Escherichia coli is a common occurrence in dairy cattle, with the highest incidence observed in calves [8,9]. Food-producing animals acquire AMR microorganisms due to several factors such as antibiotic use, forage, soil, water [3], interaction with wildlife [10,11], and by contact with humans [12,13]. AMR bacteria colonizing the animal gastrointestinal tract are shed in feces, thus favoring intra-farm spread and maintenance as well as environmental contamination via farm waste products, including untreated wastewater, sewage sludge, and organic fertilizers such as manure [3,14,15]. Adding to the control of pathogens from outside and inside the farm, biosecurity measures can therefore play a crucial role also in avoiding the selection, maintenance, and spread of AMR microbes within and outside the farm. Accordingly, although the prudent use of antibiotics is key for reducing AMR, adequate farm management practices can also play a fundamental role in containing the AMR burden [4].
With these premises, we investigated a medium-to-large herd where a very high prevalence of ESBL E. coli in the feces of calves had been identified in previous unpublished observations. To understand their prevalence, distribution, and antimicrobial resistance traits, as well as to identify possible biosecurity issues, calf feces, cow feces, and the farm and animal environment were investigated by bacteriological culture and microbial sensitivity assays, and a detailed questionnaire was administered to evaluate farming practices.

2. Results

2.1. Bacteriological Culture Results

The results obtained for all samples collected in the farm are summarized in Table 1.
ESBL E. coli was isolated from the feces of 15 of 18 (83.3%) female calves, 13 of 19 (68.4%) male calves, 2 of 3 (66.7%) cows treated for IMI, and waste milk. The feces of the dams of the enrolled calves were all negative. ESBL E. coli was also isolated from 8 of 14 (57.14%) environmental samples, including male and female calf pens, the cow feeding rack, the alley floors, the calf drinking water, and the calf feeding buckets.

2.2. Antimicrobial Susceptibility Testing of ESBL E. coli

All E. coli isolates were phenotypically positive for the double-disk synergy test (DDST), confirming the production of ESBL. However, all of them were susceptible to the carbapenem class. Based on the MIC results (Figure 1), the highest level of resistance was observed for β-lactams, with all isolates being resistant to ampicillin, cefazolin, and cefotaxime (100%), while only 2.6% of isolates were resistant to amoxicillin/clavulanic acid. Concerning aminoglycosides, 97.4% of isolates were resistant to kanamycin, 97.4% to aminosidine, and 15.4% to gentamicin. Concerning fluoroquinolones, 12.8% were resistant to enrofloxacin and 17.9% to flumequine. Resistance to florfenicol was 46.2%. Concerning sulfonamides, 84.6% were resistant to sulfisoxazole, and 48.7% to trimethoprim/sulfamethoxazole. For the tetracycline class, 89.7% of isolates were resistant. All isolates were susceptible to colistin (100%). Notably, all ESBL E. coli isolates were MDR, being resistant to at least three classes of antibiotics. The MIC results are detailed in Supplementary Materials File S1.
Table 2 reports the 12 different ESBL E. coli resistance profiles observed in this study. Profile 1 was the most frequent (10 out of 39) and was found in 9 calves (3 male and 6 female calves) and the calf feeding bucket. Profile 2 (8 of 39) was found in 7 calves (4 male and 3 female calves) and waste milk. Profile 3 (6 of 39) was found in 2 out of 3 cows treated for IMI, 3 alley floor samples, and 1 male calf. Profile 4 (4 of 39) was found in 3 female calves and 1 male calf. Profile 5 (3 of 39) was found in 2 female calves and 1 female calf pen. Profile 6 (2 of 39) was found in a male pen and the cow feeding rack. Profiles from 7 to 12 were found only once and in 4 male calves, the calf drinking water, and 1 female calf, respectively.

2.3. Hierarchical Clustering of E. coli Isolates Based on the MIC Results

Figure 2 illustrates the hierarchical clustering of ESBL E. coli isolates based on the MIC test results. Two main branches were observed. One included the isolates from 12 calves, waste milk, treated cows, and alley floors. Within this branch, all the isolates from cows and alley floors and one calf isolate were separated from the waste milk isolate and eleven calf isolates with similar AMR profiles. Another branch included 16 calf isolates and the isolates from calf pens, water and feeding buckets, and the cow feeding rack. Within this branch, one subgroup included the isolates from four calves, male pens, and the cow feeding rack, separated from the isolates from nine calves and the water and feeding buckets, while another subgroup included three calves and the female pen.
Based on the threshold Euclidean distance of 7.5, several statistically significant clusters grouped more than one sample. The largest cluster included 11 calf isolates and the waste milk isolate. The second largest cluster included the isolates from nine calves, closely related to the common feeding bucket and the calf drinking water. The third largest cluster grouped the isolates from one calf, treated cows, and the primiparous and fresh cow alleys, indicating fecal shedding from treated cows as another diffusion route. The fourth one included two female calf isolates and the female calf pens. The other four calf isolates, the male pens, and the cow feeding rack also had similar AMR profiles.

2.4. Results of the Biosecurity Questionnaire

The BioCheck.UGent biosecurity questionnaire assessed various aspects of farm management, including general farm organization, sick pen health management and outbreak management, reproduction management, calf pen management and hygiene, calf rearing, herd health management, and milking management. We identified several potential biosecurity issues that might impact ESBL maintenance and diffusion. Concerning calf management and hygiene, cleaning of teat buckets with water without detergents or disinfectants, feeding waste milk to male calves, then sharing buckets between male and female calves, mixed use of calf pens, and occasional cleaning of individual calf pens during the winter season were identified as risk factors. Regarding hygiene issues, lack of pasteurizer cleaning and occasional cleaning of troughs were identified as additional potential risk factors. Finally, the absence of a sick pen was identified as a lack of biosecurity, and the application of dry cow therapy with a first-generation cephalosporin (dihydrated cefalonium) was identified as a factor that could establish a relationship between farm practices and the occurrence and spread of AMR (Supplementary File S2).

3. Discussion

This study assessed the presence, distribution, and antimicrobial resistance profiles of ESBL-producing E. coli in a medium-sized dairy herd in Northern Italy, hosting nearly 1000 animals, including calves, heifers, and lactating and dry cows. We collected calf and cow feces, waste milk, environmental samples, and water, and we administered a questionnaire to assess the associated risk factors. As a result, most pre-weaned calves, including males and females, carried ESBL E. coli in their intestines, and ESBL E. coli was also present in the environment and farm equipment in contact with them. Not much is known about the transmission of ESBL E. coli among calves and cows, and how it is affected by environmental factors [16]. The hierarchical clustering of ESBL E. coli isolates based on the MIC results suggested that multiple MDR strains with different resistance characteristics were circulating in the farm and were found throughout sample types. Different sources and routes could therefore be involved in their dissemination and maintenance, facilitated by incorrect or inadequate management, biosecurity, and hygiene practices.
The herd management interview enabled gathering of information on potential risk factors for the distribution of ESBL microorganisms on the farm. The farmer used waste milk with antibiotic residues for feeding male calves. According to hierarchical clustering based on the isolate MIC profiles, the largest statistically significant cluster included about 40% of all calves’ fecal isolates, the feces of two out of three cows treated for mastitis that contributed to the waste milk, and the waste milk isolate. Among the risk factors associated with the spread of ESBL E. coli on cattle farms, the use of waste milk containing antibiotic residues as calf feed appears to play an important role [3,17].
Based on hierarchical clustering, the MIC profiles of the isolates from the calf feeding bucket and drinking water clustered with those of the fecal isolates of over 30% of the calves. Incorrect management practices such as shared or improperly cleaned feeding equipment [3] can favor the diffusion of AMR-carrying bacteria on the farm. Notably, the feeding buckets and calf water buckets were not cleaned with detergents or disinfectants, and sometimes not even rinsed with water between feedings; furthermore, the number of buckets was not adequate for the number of animals on the farm. ESBL E. coli was isolated from all these pieces of equipment as well as from the calf drinking water. Moreover, the pasteurizer used to reduce bacterial contamination of milk was not cleaned between cycles. Poor cleaning is one of the factors favoring bacterial contamination and multiplication, leading to higher microbial loads [18]. Indeed, we also isolated ESBL E. coli from the farm’s pasteurized waste milk. Moreover, many positive calves were females, which should not have received waste milk. Shared feeding buckets, as well as their unproper cleaning, might also facilitate the transmission of ESBL E. coli between male and female calves.
Shared calf pens and their poor hygiene may also play a role in promoting the diffusion of AMR bacteria. We isolated ESBL E. coli from both male and female calf pens, and we observed a relationship between the MIC profiles of these isolates and those from calf feces based on hierarchical clustering. As highlighted in an EFSA scientific opinion paper on calf welfare, the level of cleanliness of the areas used for housing calves is a major determinant of their health [19]. Inaccurate cleaning procedures of the single pens or calf hutches may not adequately remove fecal contamination from the walls, leading them to serve as a reservoir [16].
The cows underwent blanket dry cow therapy (BDCT) with a β-lactam, specifically dihydrated cefalonium. Although this practice is not allowed in Italy, some farms are still using it. BDCT has been reported to be linked to a significant increase in ESBL E. coli in calf feces during the colostral phase [8].
The MIC profiles of the ESBL E. coli isolated from the feces of cows treated for mastitis were similar to those of the isolates from the cows’ alley floors, suggesting fecal shedding. E. coli ESBL shedding can vary greatly among individuals [20], and antibiotic treatment for mastitis could play a role in increasing animal colonization, shedding, and subsequent environmental contamination by AMR-carrying bacteria [9]. The farm evaluated in this study did not have a sick pen, and this represents a lack of biosecurity. Early isolation of sick animals is a crucial practice for preventing the spread of pathogenic bacteria and maintaining herd health [21].
ESBL E. coli often carries multiple resistance genes for other antimicrobial drugs than β-lactams, leading to MDR [22]. All the isolates obtained in our study, from the calves, their equipment, and the farm environment, were MDR. On the other hand, resistance to colistin, an antibiotic of last resort for humans [23], was not detected, probably because many developed countries, including Italy, have prohibited its usage in food-producing animals. All ESBL E. coli isolates were also carbapenem-sensitive. This is also a positive finding, as carbapenemase-producing E. coli causes serious human infections. The study by Waade et al. conducted in Germany in 2021 reported similar results since the ESBL-producing isolates were 92.9% E. coli, and 60.6% of ESBL-producing isolates were resistant to one or more classes of antibiotics including penicillins and cephalosporins but were sensitive to carbapenems [24].

4. Materials and Methods

4.1. Farm Description and Ethics Statement

The farm was located in Northern Italy and consisted of 1000 animals of which 450 were lactating Italian Friesian cows. It is accredited free from infectious bovine rhinotracheitis (IBR) and vaccinated for neonatal diarrhea agents and type-1 and type-2 bovine viral diarrhea virus (BVDV). The farm does not use an in-house colostrum bank, but the colostrum is taken by the calves directly from the dam. The farmer used pasteurized waste milk to feed male calves. Based on the questionnaire, waste milk given to the calves was mainly represented by milk with high somatic cell count (SCC) and milk from cows treated with antibiotics. The waste milk produced on the farm at the time of the visit came from animals treated for mastitis with beta-lactam antibiotics (amoxicillin/clavulanic acid). The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Committee for Animal Welfare of the University of Milan (protocol number 99_2023).

4.2. Questionnaire

A questionnaire was completed together with the herd manager (Supplementary File S2). The questionnaire follows the Biocheck.UGent checklist [25] and was used to assess different aspects of herd management, the use of antibiotics, and farm biosecurity. The questionnaire was also integrated with further aspects based on previous studies on ESBL E. coli risk factors [9,17,26]. The form was divided into several sections: I. General questions about farm organization: how many animals are present in the different categories, who works with the animals; II. Health management in the sick pen and management of outbreaks; III. Reproduction management; IV. Calving pen management and hygiene questions; V. Calf rearing: colostrum feeding management, milk feeding management, calf housing, vaccinations, and treatments; VI. Health management of the herd; VII. Milking management.

4.3. Animals and Sample Collection

We collected fecal samples from 37 healthy dairy calves (19 males, 18 females) aged 7–21 days. All calves were free from diarrhea and had not been treated with antibiotics. Males were fed waste milk, while females received commercial milk replacer. We sampled the feces of the 26 dams present on the farm (the 9 missing dams had been sold or sent to the slaughterhouse) and of 3 cows treated for intramammary infection (IMI) with amoxicillin/clavulanic acid that contributed to the waste milk. All the fecal samples were collected from the rectal ampoule using gloves, transported to the laboratory in refrigerated conditions, and frozen at −20 °C for two to five days until analysis [27]. Waste milk was collected directly from the pasteurizer and kept refrigerated until arrival at the laboratory. Three calf pens were sampled by rubbing sterile gauzes against the inner wall of the pens over an area of about 150 × 30 cm2 at the height of the calves’ noses, avoiding obvious fecal smears, then stored in sterile 50 mL Falcon® tubes. During the sampling process, two separate sterile swabs were used. One swab was rubbed thoroughly against the bottom and inner wall of a calf feeding bucket, while the other swab was used to collect samples from the inside of the nipple. Two water samples of 150 mL were collected into sterile containers from the calf watering buckets and one from the cow watering trough, respectively. Two environmental samples were also taken with gauzes from the cow feeding rack and one from the cow’s berth tube. Disposable fabric socks were used to collect three samples from the barn floors by walking down the alleys one time, and then inserted in sterile plastic bags: one from the cow alley, one from the primiparous cow alley, and one from the fresh cow alley, respectively. All environmental and water samples were stored at refrigerated temperature until arrival at the laboratory.

4.4. Isolation and Characterization of ESBL-Producing E. coli

Environmental swabs and feces (0.1 g) were enriched in 5 mL of Müeller Hinton broth (Microbiol, Cagliari, Italy) and incubated at 37 °C under aerobic conditions for 18–24 h. For environmental samples, 30 mL of Müeller Hinton broth was added to the Falcon tubes and plastic bags containing the samples and incubated at 37 °C for 18–24 h. One-hundred milliliters of water was added to an equal amount of double-strength enrichment broth and incubated at 37 °C for 48 h. All the feces and environmental samples were cultured on CHROMagar™ ESBL agar plates (CHROMagar, Paris, France) and MacConkey agar as a control medium (Oxoid Ltd., Basingstoke, UK), and incubated at 37 °C for 18–24 h. Pasteurized waste milk was seeded on blood agar plates (Microbiol, Cagliari, Italy) and CHROMagar™ ESBL agar plates in amounts of 100 μL and incubated at 37 °C for 24 h. Colonies indicating ESBL bacteria grown on CHROMagar™ ESBL agar plates were picked and submitted to species identification with the MBT Microflex LT/SH MALDI-TOF mass spectrometer (Bruker Daltonik GmbH, Bremen, Germany) as described previously [28]. After species identification, the colonies recovered from CHROMagar™ ESBL agar plates were sub-cultured on blood agar plates (Microbiol, Cagliari, Italy) and subjected to ESBL phenotyping assessment using the double-disk synergy test (DDST) to assess carbapenemase production according to the EUCAST guidelines [29].

4.5. Antimicrobial Susceptibility Testing

A SensititreTM ITISVE1 plate (Thermo Fisher Scientific®, Waltham, MA, USA) was used to determine the MIC of the antimicrobials commonly used in dairy herds against the ESBL E. coli isolates. The plate contained the following antibiotics: flumequine (range 1–16 μg/mL); amoxicillin/clavulanic acid (0.25–32 μg/mL); ampicillin (0.25–32 μg/mL); cefazolin (0.5–8 μg/mL); cefotaxime (0.5–4 μg/mL); sulfisoxazole (128–512 μg/mL); colistin (0.03–8 μg/mL); enrofloxacin (0.02–32 μg/mL); florfenicol (1–64 μg/mL); gentamicin (0.25–32 μg/mL); tetracycline (0.5–16 μg/mL); trimethoprim/sulfamethoxazole (0.06–16 μg/mL); aminosidine (1–32 μg/mL); kanamycin (2–32 μg/mL). Quality control for Sensititre plates was performed using E. coli strain ATCC 25922 and the Sensititre™ SWIN™ Software System V. 3.4 (3.4.6.2) (SensititreTM, Thermo Fisher Scientific®, Waltham, MA, USA). The MIC results were interpreted according to the manufacturer’s instructions using CLSI VET08 4th edition [30] (V = Vet), CLSI VET06 1st edition [31] (V = Vet), CLSI M100 29th edition (H = Human) [32], EUCAST v.11.0 [33], CASFM 2019 [34]. ESBL E. coli isolates resistant to at least 3 classes of antibiotics were classified as MDR [35], and intermediate isolates were classified as susceptible.

4.6. Hierarchical Clustering

Non-supervised hierarchical cluster analysis using Ward’s method was performed based on the MIC values [36,37]. A total of 21 parameters were obtained by assigning to each MIC value ranging from >512 μg/mL to ≤0.015625 a number from 1 to 21 according to decreasing antibiotic concentrations. The profiles obtained for each sample after the conversion were used to construct a dendrogram. This technique was chosen for its effectiveness in minimizing variance within the clusters, allowing us to identify groups of isolates with similar resistance patterns. The resulting dendrogram provides a visual representation of the progressive merging of the clusters based on the Euclidean distance. The dendrogram was cut (maximum distance for clustering) at a height of 7.5. This cut-off point was chosen based on statistical significance, ensuring that each cluster represented a distinctive group of isolates with similar characteristics. The analysis was conducted using the SciPy library (version 1.11.4, https://scipy.org/, accessed on 18 January 2024) within the Python environment (version 3.10.12, https://www.python.org/, accessed on 18 January 2024).

5. Conclusions

This study highlighted the widespread presence of ESBL E. coli in the dairy farm and the relevant presence and circulation of MDR strains in association with different sources and sample types. Prudent antibiotic use remains the most relevant driver enabling the reduction in and control of AMR bacteria. Nevertheless, adherence to good internal and external biosecurity practices, hygiene of facilities and equipment, correct feeding procedures, and correct animal management might also significantly contribute to reducing and controlling AMR bacteria.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/antibiotics13030241/s1, Supplementary File S1: MIC values expressed in µg/mL for the ESBL E. coli isolates assessed in this study with the plate assay. Supplementary File S2: Questionnaire of the study Multidrug-resistant extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli in a dairy herd: distribution and antimicrobial resistance profiles.

Author Contributions

Conceptualization: M.P., R.P. and M.F.A.; methodology, M.P., R.P., M.F.A., A.G., F.U. and P.M.; farm activities and sample collection: M.P. and L.F.P.; formal analysis: M.P., L.F.P. and L.M.; resources: R.P. and M.F.A.; data curation: M.P., A.G. and M.F.A.; writing, original draft: M.P. and M.F.A.; writing, review and editing, all authors; supervision: R.P. and M.F.A. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding. All funds were from the University of Milan.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Committee for Animal Welfare of the University of Milan (protocol number 99_2023).

Informed Consent Statement

Written informed consent has been obtained from the farmer to publish this paper.

Data Availability Statement

All pertinent data generated in this study are provided in the Supplementary Materials.

Acknowledgments

Fernando Ulloa was supported by a fellowship from the Universidad Austral de Chile.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Antimicrobial Resistance Surveillance in Europe 2022—2020 Data. Available online: https://www.ecdc.europa.eu/en/publications-data/antimicrobial-resistance-surveillance-europe-2022-2020-data (accessed on 29 January 2024).
  2. Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report: 2022. Available online: https://www.who.int/publications-detail-redirect/9789240062702 (accessed on 29 January 2024).
  3. Ma, Z.; Lee, S.; Jeong, K.C. Mitigating Antibiotic Resistance at the Livestock-Environment Interface: A Review. J. Microbiol. Biotechnol. 2019, 29, 1683–1692. [Google Scholar] [CrossRef]
  4. European Centre for Disease Prevention and Control; European Food Safety Authority; European Medicines Agency. Third Joint Inter-Agency Report on Integrated Analysis of Consumption of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Bacteria from Humans and Food-Producing Animals in the EU/EEA. EFSA J. 2021, 19, e06712. [Google Scholar] [CrossRef]
  5. Cuong, N.V.; Padungtod, P.; Thwaites, G.; Carrique-Mas, J.J. Antimicrobial Usage in Animal Production: A Review of the Literature with a Focus on Low- and Middle-Income Countries. Antibiotics 2018, 7, 75. [Google Scholar] [CrossRef] [PubMed]
  6. Reygaert, W.C. An Overview of the Antimicrobial Resistance Mechanisms of Bacteria. AIMS Microbiol. 2018, 4, 482–501. [Google Scholar] [CrossRef] [PubMed]
  7. Rawat, D.; Nair, D. Extended-Spectrum β-Lactamases in Gram Negative Bacteria. J. Glob. Infect. Dis. 2010, 2, 263–274. [Google Scholar] [CrossRef]
  8. Tetens, J.L.; Billerbeck, S.; Schwenker, J.A.; Hölzel, C.S. Short Communication: Selection of Extended-Spectrum β-Lactamase-Producing Escherichia coli in Dairy Calves Associated with Antibiotic Dry Cow Therapy—A Cohort Study. J. Dairy. Sci. 2019, 102, 11449–11452. [Google Scholar] [CrossRef]
  9. Gonggrijp, M.A.; Santman-Berends, I.M.G.A.; Heuvelink, A.E.; Buter, G.J.; van Schaik, G.; Hage, J.J.; Lam, T.J.G.M. Prevalence and Risk Factors for Extended-Spectrum β-Lactamase- and AmpC-Producing Escherichia coli in Dairy Farms. J. Dairy. Sci. 2016, 99, 9001–9013. [Google Scholar] [CrossRef]
  10. Prandi, I.; Bellato, A.; Nebbia, P.; Stella, M.C.; Ala, U.; von Degerfeld, M.M.; Quaranta, G.; Robino, P. Antibiotic Resistant Escherichia coli in Wild Birds Hospitalised in a Wildlife Rescue Centre. Comp. Immunol. Microbiol. Infect. Dis. 2023, 93, 101945. [Google Scholar] [CrossRef] [PubMed]
  11. Musa, L.; Stefanetti, V.; Casagrande Proietti, P.; Grilli, G.; Gobbi, M.; Toppi, V.; Brustenga, L.; Magistrali, C.F.; Franciosini, M.P. Antimicrobial Susceptibility of Commensal E. coli Isolated from Wild Birds in Umbria (Central Italy). Animals 2023, 13, 1776. [Google Scholar] [CrossRef]
  12. Collignon, P.J.; McEwen, S.A. One Health-Its Importance in Helping to Better Control Antimicrobial Resistance. Trop. Med. Infect. Dis. 2019, 4, 22. [Google Scholar] [CrossRef]
  13. Ramatla, T.; Mafokwane, T.; Lekota, K.; Monyama, M.; Khasapane, G.; Serage, N.; Nkhebenyane, J.; Bezuidenhout, C.; Thekisoe, O. “One Health” Perspective on Prevalence of Co-Existing Extended-Spectrum β-Lactamase (ESBL)-Producing Escherichia coli and Klebsiella Pneumoniae: A Comprehensive Systematic Review and Meta-Analysis. Ann. Clin. Microbiol. Antimicrob. 2023, 22, 88. [Google Scholar] [CrossRef]
  14. Massé, J.; Lardé, H.; Fairbrother, J.M.; Roy, J.-P.; Francoz, D.; Dufour, S.; Archambault, M. Prevalence of Antimicrobial Resistance and Characteristics of Escherichia coli Isolates From Fecal and Manure Pit Samples on Dairy Farms in the Province of Québec, Canada. Front. Vet. Sci. 2021, 8, 654125. [Google Scholar] [CrossRef]
  15. Cho, S.; Jackson, C.R.; Frye, J.G. Freshwater Environment as a Reservoir of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae. J. Appl. Microbiol. 2023, 134, lxad034. [Google Scholar] [CrossRef]
  16. Homeier-Bachmann, T.; Kleist, J.F.; Schütz, A.K.; Bachmann, L. Distribution of ESBL/AmpC-Escherichia coli on a Dairy Farm. Antibiotics 2022, 11, 940. [Google Scholar] [CrossRef]
  17. Weber, L.P.; Dreyer, S.; Heppelmann, M.; Schaufler, K.; Homeier-Bachmann, T.; Bachmann, L. Prevalence and Risk Factors for ESBL/AmpC-E. coli in Pre-Weaned Dairy Calves on Dairy Farms in Germany. Microorganisms 2021, 9, 2135. [Google Scholar] [CrossRef]
  18. Elizondo-Salazar, J.; Jones, C.; Heinrichs, A. Evaluation of Calf Milk Pasteurization Systems on 6 Pennsylvania Dairy Farms. J. Dairy. Sci. 2010, 93, 5509–5513. [Google Scholar] [CrossRef] [PubMed]
  19. EFSA Panel on Biological Hazards (BIOHAZ); Koutsoumanis, K.; Allende, A.; Álvarez-Ordóñez, A.; Bolton, D.; Bover-Cid, S.; Chemaly, M.; de Cesare, A.; Hilbert, F.; Lindqvist, R.; et al. Update of the List of Qualified Presumption of Safety (QPS) Recommended Microorganisms Intentionally Added to Food or Feed as Notified to EFSA. EFSA J. 2023, 21, e07747. [Google Scholar] [CrossRef]
  20. Munns, K.D.; Selinger, L.B.; Stanford, K.; Guan, L.; Callaway, T.R.; McAllister, T.A. Perspectives on Super-Shedding of Escherichia coli O157:H7 by Cattle. Foodborne Pathog. Dis. 2015, 12, 89–103. [Google Scholar] [CrossRef] [PubMed]
  21. Power, G.M.; Renaud, D.L.; Miltenburg, C.; Spence, K.L.; Hagen, B.N.M.; Winder, C.B. Perceptions of Biosecurity in a Canadian Dairy Context. J. Dairy. Sci. 2024. [Google Scholar] [CrossRef] [PubMed]
  22. Ibrahim, D.R.; Dodd, C.E.R.; Stekel, D.J.; Meshioye, R.T.; Diggle, M.; Lister, M.; Hobman, J.L. Multidrug-Resistant ESBL-Producing E. coli in Clinical Samples from the UK. Antibiotics 2023, 12, 169. [Google Scholar] [CrossRef] [PubMed]
  23. European Medicines Agency. Categorisation of Antibiotics for Use in Animals, 2020. Available online: https://www.ema.europa.eu/en/documents/report/categorisation-antibiotics-european-union-answer-request-european-commission-updating-scientific-advice-impact-public-health-and-animal-health-use-antibiotics-animals_en.pdf (accessed on 25 February 2024).
  24. Waade, J.; Seibt, U.; Honscha, W.; Rachidi, F.; Starke, A.; Speck, S.; Truyen, U. Multidrug-Resistant Enterobacteria in Newborn Dairy Calves in Germany. PLoS ONE 2021, 16, e0248291. [Google Scholar] [CrossRef] [PubMed]
  25. Home|Biocheck.UGent. Available online: https://biocheckgent.com/en (accessed on 29 January 2024).
  26. Santman-Berends, I.M.G.A.; Gonggrijp, M.A.; Hage, J.J.; Heuvelink, A.E.; Velthuis, A.; Lam, T.J.G.M.; van Schaik, G. Prevalence and Risk Factors for Extended-Spectrum β-Lactamase or AmpC-Producing Escherichia coli in Organic Dairy Herds in the Netherlands. J. Dairy. Sci. 2017, 100, 562–571. [Google Scholar] [CrossRef] [PubMed]
  27. Achá, S.J.; Kühn, I.; Mbazima, G.; Colque-Navarro, P.; Möllby, R. Changes of Viability and Composition of the Escherichia coli Flora in Faecal Samples during Long Time Storage. J. Microbiol. Methods 2005, 63, 229–238. [Google Scholar] [CrossRef] [PubMed]
  28. Rosa, N.M.; Penati, M.; Fusar-Poli, S.; Addis, M.F.; Tola, S. Species Identification by MALDI-TOF MS and gap PCR–RFLP of Non-aureus Staphylococcus, Mammaliicoccus, and Streptococcus spp. Associated with Sheep and Goat Mastitis. Vet. Res. 2022, 53, 84. [Google Scholar] [CrossRef]
  29. Clinical & Laboratory Standards Institute: CLSI Guidelines. Available online: https://clsi.org/ (accessed on 13 February 2023).
  30. Lubbers, B.V.; Clinical and Laboratory Standards Institute (Eds.) Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals, 4th ed.; VET08; Clinical and Laboratory Standards Institute, CLSI: Wayne, PA, USA, 2018; ISBN 978-1-68440-010-2. [Google Scholar]
  31. Traczewski, M.M.; Clinical and Laboratory Standards Institute (Eds.) Methods for Antimicrobial Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria Isolated from Animals, 1st ed.; VET06; Clinical and Laboratory Standards Institute, CLSI: Wayne, PA, USA, 2017; ISBN 978-1-56238-810-2. [Google Scholar]
  32. Weinstein, M.P.; Ii, J.S.L. Performance Standards for Antimicrobial Susceptibility Testing, 34th ed.; M100; Clinical and Laboratory Standards Institute, CLSI: Wayne, PA, USA, 2024; ISBN 978-1-68440-221-2. [Google Scholar]
  33. Eucast: Clinical Breakpoints and Dosing of Antibiotics. Available online: https://www.eucast.org/clinical_breakpoints (accessed on 13 February 2023).
  34. Comité de l’antibiogramme de la Société Francaise de Microbiologie (CASFM)2019_V1.0.Pdf. Break Point Suggested by the French Society of Microbiology in Veterinary Medicine. Available online: https://www.sfm-microbiologie.org/wp-content/uploads/2019/01/CASFM_VET2018.pdf (accessed on 25 February 2024).
  35. Magiorakos, A.-P.; Srinivasan, A.; Carey, R.B.; Carmeli, Y.; Falagas, M.E.; Giske, C.G.; Harbarth, S.; Hindler, J.F.; Kahlmeter, G.; Olsson-Liljequist, B.; et al. Multidrug-Resistant, Extensively Drug-Resistant and Pandrug-Resistant Bacteria: An International Expert Proposal for Interim Standard Definitions for Acquired Resistance. Clin. Microbiol. Infect. 2012, 18, 268–281. [Google Scholar] [CrossRef]
  36. Berrazeg, M.; Drissi, M.; Medjahed, L.; Rolain, J.M. Hierarchical Clustering as a Rapid Tool for Surveillance of Emerging Antibiotic-Resistance Phenotypes in Klebsiella pneumoniae Strains. J. Med. Microbiol. 2013, 62, 864–874. [Google Scholar] [CrossRef]
  37. Ward, J.H., Jr. Hierarchical Grouping to Optimize an Objective Function. J. Am. Stat. Assoc. 1963, 58, 236–244. [Google Scholar] [CrossRef]
Figure 1. Distribution of resistance and susceptibility of the ESBL E. coli isolates to the different antimicrobials according to the plate MIC test.
Figure 1. Distribution of resistance and susceptibility of the ESBL E. coli isolates to the different antimicrobials according to the plate MIC test.
Antibiotics 13 00241 g001
Figure 2. Hierarchical clustering of the ESBL E. coli isolates’ MIC profiles based on Ward’s method. Female calves (F) are illustrated in red. Male calves (M) are illustrated in blue. Cows, environment, and water samples are illustrated in gold. The dotted line indicates the significant Euclidean distance cut-off point at 7.5.
Figure 2. Hierarchical clustering of the ESBL E. coli isolates’ MIC profiles based on Ward’s method. Female calves (F) are illustrated in red. Male calves (M) are illustrated in blue. Cows, environment, and water samples are illustrated in gold. The dotted line indicates the significant Euclidean distance cut-off point at 7.5.
Antibiotics 13 00241 g002
Table 1. Summary of analyzed samples and respective bacteriological results.
Table 1. Summary of analyzed samples and respective bacteriological results.
Sample TypenESBL E. coli (%)
Female calf feces1815 (83.3%)
Male calf feces1913 (68.4%)
Treated cow feces32 (66%)
Dam feces260
Waste milk11 (100%)
Male calf pens11 (100%)
Female calf pens11 (100%)
Mixed-use calf pens10
Calf feeding bucket21 (50%)
Calf drinking water21 (50%)
Cow alleys33 (100%)
Cow’s berth tube10
Cow water trough10
Cow feeding rack21 (50%)
Table 2. Antimicrobial resistance profiles of the ESBL E. coli isolates. R, resistant; S, sensitive; MDR, multidrug-resistant. The number of antimicrobial classes is reported in parentheses.
Table 2. Antimicrobial resistance profiles of the ESBL E. coli isolates. R, resistant; S, sensitive; MDR, multidrug-resistant. The number of antimicrobial classes is reported in parentheses.
Resistance ProfileNumber of IsolatesAminosidineAmoxicillin/Clavulanic AcidAmpicillinCefazolinCefotaximeColistinEnrofloxacinFlorfenicolFlumequineGentamicinKanamycinSulfisoxazoleTetracyclineTrimethoprim/SulfamethoxazoleMDR (Class Number)
110RSRRRSSRSSRRRR(5)
28RSRRRSSSSSRRRS(4)
36RSRRRSSSSSRSRS(3)
44RSRRRSSRSSRRRS(5)
53RSRRRSRSRSRRSR(4)
62RSRRRSSRSRRRRR(5)
71RSRRRSSSRRRRRS(5)
81SSRRRSSSSSSRRR(3)
91RSRRRSSSRRRRSR(4)
101RSRRRSRSRSRRRR(5)
111RSRRRSSRSRRRRS(5)
121RRRRRSRRRRRRRR(6)
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Penati, M.; Musa, L.; Filippone Pavesi, L.; Guaraglia, A.; Ulloa, F.; Moroni, P.; Piccinini, R.; Addis, M.F. Multidrug-Resistant Extended-Spectrum Beta-Lactamase (ESBL)-Producing Escherichia coli in a Dairy Herd: Distribution and Antimicrobial Resistance Profiles. Antibiotics 2024, 13, 241. https://doi.org/10.3390/antibiotics13030241

AMA Style

Penati M, Musa L, Filippone Pavesi L, Guaraglia A, Ulloa F, Moroni P, Piccinini R, Addis MF. Multidrug-Resistant Extended-Spectrum Beta-Lactamase (ESBL)-Producing Escherichia coli in a Dairy Herd: Distribution and Antimicrobial Resistance Profiles. Antibiotics. 2024; 13(3):241. https://doi.org/10.3390/antibiotics13030241

Chicago/Turabian Style

Penati, Martina, Laura Musa, Laura Filippone Pavesi, Alessandro Guaraglia, Fernando Ulloa, Paolo Moroni, Renata Piccinini, and Maria Filippa Addis. 2024. "Multidrug-Resistant Extended-Spectrum Beta-Lactamase (ESBL)-Producing Escherichia coli in a Dairy Herd: Distribution and Antimicrobial Resistance Profiles" Antibiotics 13, no. 3: 241. https://doi.org/10.3390/antibiotics13030241

APA Style

Penati, M., Musa, L., Filippone Pavesi, L., Guaraglia, A., Ulloa, F., Moroni, P., Piccinini, R., & Addis, M. F. (2024). Multidrug-Resistant Extended-Spectrum Beta-Lactamase (ESBL)-Producing Escherichia coli in a Dairy Herd: Distribution and Antimicrobial Resistance Profiles. Antibiotics, 13(3), 241. https://doi.org/10.3390/antibiotics13030241

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop